脊柱转移瘤的诊治及分子标记物的研究进展

发布时间：2018-02-03 08:09

本文关键词： 癌症脊柱转移瘤诊断治疗分子标记物　出处：《河北医科大学》2017年硕士论文　论文类型：学位论文

【摘要】：随着医学技术及观念的进步,癌症患者的生存期越来越长,脊柱转移瘤的发病率亦逐年增高,其主要表现为疼痛、神经功能障碍和脊柱不稳等,这些症状严重影响着患者的生活质量和预后。目前,外科治疗依然是脊柱转移瘤的最重要的治疗手段,但越来越多的治疗策略正在呈现出来,脊柱微创手术的快速发展明显减少了患者的术后并发症,立体定向放疗为脊柱转移瘤提供更精准的定位及可靠的疗效,与此同时,靶向治疗、免疫治疗药物的效果亦收到了确切的临床效果。相信通过多学科的共同努力,脊柱转移瘤患者的生活质量及生存期将会得到大幅度提升。
[Abstract]:With the development of medical technology and concept, the survival time of cancer patients is longer and longer, and the incidence of spinal metastases is increasing year by year. The main manifestations of cancer are pain, neurological dysfunction and spinal instability. These symptoms seriously affect the quality of life and prognosis of patients. At present, surgical treatment is still the most important treatment of spinal metastases, but more and more treatment strategies are emerging. The rapid development of minimally invasive spinal surgery significantly reduces postoperative complications. Stereotactic radiotherapy provides a more accurate location and reliable efficacy for spinal metastases, while targeted therapy. It is believed that the quality of life and survival of patients with spinal metastases will be greatly improved through the joint efforts of many disciplines.
【学位授予单位】：河北医科大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R738.1

【参考文献】